These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people
ECDC is now offering a series of micro learning activities related to COVID-19 (the disease causing the 2019 novel coronavirus outbreak). The e-learning activities are available in the ECDC Virtual Academy (EVA). https://eva.ecdc.europa.eu/mod/scorm/view.php?id=9691
The short e-learning activitie...s provide guidance on the application of non-pharmaceutical countermeasures and include five sessions.
1. Introduction to COVID-19 NPC
2. Personal protection against COVID-19
3. Environmental countermeasures against COVID-19
4. Social distancing countermeasures against COVID-19
5. Travel-related countermeasures against COVID-19
more
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ...be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.
more
This briefing note summarises key mental health and psychosocial support (MHPSS) considerations in relation to the 2019 novel coronavirus (COVID-19) outbreak.
WHO is launching a messaging service with partners WhatsApp and Facebook to keep people safe from coronavirus.
WHO has launched a dedicated messaging services in Arabic, English, French, Hindi, Italian, Spanish and Portuguese with partners WhatsApp and Facebook to keep people safe from coronaviru...s. This easy-to-use messaging service has the potential to reach 2 billion people and enables WHO to get information directly into the hands of the people that need it.
more
This course consists of a video which provides an introduction to COVID-19 in Indian Sign Language.
Coronaviruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Res...piratory Syndrome (SARS).
A novel coronavirus (COVID-19) was identified in 2019 in Wuhan, China. This is a new coronavirus that has not been previously identified in humans.
This course consists of a video which provides an introduction to COVID-19 in Indian Sign Language.
more
This page aims to support researchers and interested individuals by providing tools and data sets related to the Coronavirus disease 2019 (COVID-19) outbreak and the SARS-CoV-2 virus.
The Stephen B. Thacker CDC Library is collecting COVID-19 (2019 Novel Coronavirus) research articles and compiling them into an easily accessible and downloadable database to help researchers find the latest COVID-19 research
This database is updated every day, Monday through Friday, by systematica...lly searching various bibliographic databases and hand searching selected grey literature sources including preprints from bioRxiv, medRxiv, chemRxiv, and SSRN. The methodology is posted on the website.
You can search the database of citations by author, keyword (in title, author, abstract, subject headings fields), journal, or abstract when available. DOI, PMID, and URL links are included when available.
more
Esta nota de instrução resume as principais considerações em Saúde Mental e Apoio Psicossocial (SMAPS) referen-tes ao novo surto de coronavírus (COVID-19). Este documento foi atualizado pela última vez em 17 de março de 2020.
Diante da natureza patogênica e virulenta do vírus SARS-CoV-2 e da evolução da epidemia de COVID, o governo decidiu, dia 15 de março de 2020, impor restrições à circulação da população para reduzir a propagação do vírus, proteger as pessoas em risco e preservar as cap...acidades do nosso sistema de saúde. O estrito respeito dos gestos de barreira sanitária foi enfatizado como corolário essencial dessas medidas.
more
Em janeiro de 2020, a Organização Mundial da Saúde (OMS) declarou o surto da doença do novo coronavírus como Emergência de Saúde Pública de Importância Internacional. A OMS afirmou que havia um alto risco de que a doença do coronavírus 2019 (COVID-19) se espalhasse por outros países no m...undo todo. Em março de 2020, a OMS avaliou que a COVID-19 podia ser caracterizada como pandemia. A OMS e autoridades de saúde pública no mundo todo estão agindo para conter o surto da COVID-19. Entretanto, essa crise está gerando estresse na população. Essas considerações de saúde mental foram desenvolvidas pelo Departamento de Saúde Mental e Uso de Substâncias da OMS como uma série de mensagens dirigidas a diferentes grupos para apoiar o bem-estar mental e psicossocial durante o surto de COVID-19.
more
The Slum and Rural Health Initiative of Nigeria (SRHIN) has developed behavioural change communication messages on prevention of coronavirus in the form of easy-to-read infographics in over 70 local languages.
This document provides guidance to African Union Member States on key mental health and psychosocial support (MHPSS) considerations in relation to the coronavirus disease 2019 (COVID-19) pandemic. It contains useful guidance on MHPSS for the community, healthcare workers, caregivers of vulnerable po...pulations and people in quarantine, isolation or treatment centers(1)
(2). This guidance aims to provide practical steps to reduce stress, anxiety, stigma and psychological disorders associated with COVID-19 and improve overall mental health and well being. This guidance can be used for planning purposes by policy makers and Ministries of
health and institutions coordinating emergency response to COVID-19 response by Member States. It can also be disseminated to stakeholders.
more
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...tion strategies and case management. More and more immunodiagnostics, mostly rapid diagnostic tests, are being made available as an alternative to NAATs. This type of test can be used out-of-laboratory conditions at large scale.
more
Auf dieser Seiten finden Sie wichtige Hygienetipps, Verhaltensregeln und –empfehlungen zur Vorbeugung von Infektionen mit dem Coronavirus SARS-CoV-2 in Kindertagesstätten und den verschiedenen Schulformen. Es können Poster, Flyer, Videos und Printmaterial heruntergeladen werden
As of 21 May 2020, 4.8 million confirmed cases of Coronavirus disease 2019 (COVID-19) have been reported globally. In South America, COVID-19 was first detected on 26 February 2020, when Brazil confirmed a case in São Paulo.
his guidance details basic decontamination principles and procedures that should be followed to decontaminate the physical environment in the context of the coronavirus disease 2019 (COVID-19) pandemic. Surface contamination and transmission risk all differ by the type of setting and the volume of p...eople that frequent each setting (e.g. healthcare facilities, public transport, and other busy facilities/workplaces), even though the principles of environmental decontamination remain the same.
more
– векторною вакциною – (Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson)
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit Vektor-Impfstoff – (COVID-19 Vacc...ine Janssen® von Janssen Cilag International/Johnson & Johnson)
more
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer... und Spikevax® von Moderna)
more
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...й лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)
(Grundimmunisierung und Auffrischimpfungen) – mit Vektor-Impfstoff – (COVID-19 Vaccine Janssen® von Janssen Cilag International/Johnson & Johnson)
Stand: 14. Februar 2022 (dieses Aufklärungsmerkblatt wird laufend aktualisiert)
more